Superior Vena Caval Obstruction: An Analysis of Seventy-Six Cases, with Comments on the Safety of Venography

Davies, P. F.; Shevland, J. E.
June 1985
Angiology;Jun1985, Vol. 36 Issue 6, p354
Academic Journal
Seventy-six cases of superior vena caval obstruction (SVCO) were documented in the period 1970-1980. There were 53 males and 23 females, with a mean age of 61.7 years. The underlying causes were:- a) Lung cancer 64/76 84.2% b) Metastatic disease 4/76 5.3% c) Lymphoma 4/76 5.3% d) Benign aetiology 2/76 2.6% e) Undiagnosed 2/76 2.6% 97.4% of the cases were due to malignancy. Of 61 patients on whom follow-up is available, only one is alive. Eighty-two percent of this group died within one year following the onset of SVCO. Autopsies were performed on 17 patients. Nine of these (52.9%) showed invasion of the superior vena cava, 6 (35.3%) showed compression without invasion, and 2 (11.8%) showed neither compression nor invasion following Radiotherapy. Venography was performed on all patients with only one minor complication being recorded.


Related Articles

  • Comorbidity-Adjusted Survival in Early Stage Lung Cancer Patients Treated with Hypofractionated Proton Therapy. Dod, Sharon Y.; Bush, David A.; Slater, Jerry D. // Journal of Oncology;2010, p1 

    Objective. To determine the influence of comorbidity on survival in early-stage lung cancer patients treated with proton radiotherapy, using the Charlson Comorbidity Index. Study Design and Setting. Fifty-four non-small-cell lung cancer patients, treated prospectively in a phase II clinical...

  • Symptom Clusters in Patients with Cancer with Metastatic Bone Pain. Hadi, Stephanie; Fan, Grace; Hird, Amanda E.; Kirou-Mauro, Andrea; Filipczak, Linda A.; Chow, Edward // Journal of Palliative Medicine;May2008, Vol. 11 Issue 4, p591 

    Purpose: The primary objective was to explore how patients' worst pain clustered together with functional interference items. Secondary objectives were to determine whether symptom clusters change with palliative radiotherapy (RT) and to compare the difference between responders and...

  • Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Oster, Gerry; Lamerato, Lois; Glass, Andrew G.; Richert-Boe, Kathryn E.; Lopez, Andrea; Chung, Karen; Richhariya, Akshara; Dodge, Tracy; Wolff, Greg G.; Balakumaran, Arun; Edelsberg, John // Supportive Care in Cancer;Dec2013, Vol. 21 Issue 12, p3279 

    Purpose: To document the risk of skeletal complications in patients with bone metastases from breast cancer (BC), lung cancer (LC), or prostate cancer (PC) in routine clinical practice. Methods: We used data from two large US health systems to identify patients aged ≥18 years with...

  • Can clinical factors be determinants of bone metastases in non-small cell lung cancer? Ursavas, Ahmet; Karadag, Mehmet; Uzaslan, Esra; Rodoplu, Erkan; Demirdögen, Ezgi; Burgazlioglu, Basak; Gozu, R. Oktay // Annals of Thoracic Medicine;Jan-Mar2007, Vol. 2 Issue 1, p9 

    OBJECTIVE: The aim of this study was to investigate the correlations among symptoms, laboratory findings of bone metastasis and whole body bone scanning (WBBS) and the frequency of occurrence of bone metastases MATERIALS AND METHODS: Hundred and six patients who were diagnosed with non-small...

  • Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study. Piantedosi, F. V.; Caputo, F.; Mazzarella, G.; Gilli, M.; Pontillo, A.; D'Agostino, D.; Campbell, S.; Marsico, S. A.; Bianco, A. // Cancer Chemotherapy & Pharmacology;Apr2008, Vol. 61 Issue 5, p803 

    Although platinum-based two-drug combinations represent the elective therapeutic approach for advanced/metastatic NSCLC, there is still interest in exploring the efficacy and tolerability of platinum-free combinations including third generation agents in selected NSCLC population. Based on the...

  • Computed tomography-guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer. Wei, Zhigang; Zhang, Kaixian; Ye, Xin; Yang, Xia; Zheng, Aimin; Huang, Guanghui; Wang, Jiao // Skeletal Radiology;Oct2015, Vol. 44 Issue 10, p1485 

    Objective: To retrospectively evaluate the efficacy and safety of microwave ablation (MWA) combined with osteoplasty in lung cancer patients with painful extraspinal bone metastases. Materials and methods: From January 2011 to July 2014, 26 lung cancer patients with 33 painful extraspinal bone...

  • Patients' and Physicians' Preferences for Approaches to Bone Metastases Treatment in Turkey. GATTA, Francesca; GONZALEZ, Juan Marcos; ERTUGRUL, Gulnihal; Yi QIAN; HAUBER, A. Brett; POSNER, Joshua; OKSUZOGLU, Berna; ARELLANO, Jorge // International Journal of Hematology & Oncology / UHOD: Uluslarar;2015, Vol. 25 Issue 2, p118 

    Bone metastases and associated skeletal-related events (SREs) are common in patients with advanced breast, lung, and prostate cancer. Bone-targeted agents (BTAs) are available for the treatment of bone metastases, but little is known about patients' and physicians' preferences for the various...

  • Inflammatory sternal metastasis heralding lung cancer: two cases. Bachmeyer, Claude; Langman, Benjamin; Kazerouni, Firouze; Charoud, Abdel; Mougeot-Martin, Miette // Clinical Rheumatology;Jun2006, Vol. 25 Issue 3, p409 

    Bone pain due to bone metastases is a frequent presenting symptom of lung cancer. However, sternal metastases are unusual. We report two patients with inflammatory sternal metastases mimicking osteitis and indicating lung cancer. Chest computed tomography scan showed lytic lesion of the sternal...

  • The stability of osseous metastases of the spine in lung cancer - a retrospective analysis of 338 cases. Rief, Harald; Bischof, Marc; Bruckner, Thomas; Welzel, Thomas; Askoxylakis, Vasileios; Rieken, Stefan; Lindel, Katja; Combs, Stephanie; Debus, Jürgen // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background: The objective of this retrospective analysis is to systematically assess osseous lesions on the basis of a validated scoring system in terms of stability and fractures prior to and following radiotherapy in 338 lung cancer patients with bone metastases in the vertebral column....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics